WINNIPEG, MANITOBA -- (MARKET WIRE) -- March 07, 2007 -- Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products is pleased to announce the launch of its enhanced corporate website.
